Jeffrey N. Simmons - 06 Feb 2026 Form 4 Insider Report for Elanco Animal Health Inc (ELAN)

Role: PRESIDENT, CEO AND DIRECTOR, Director
Signature: /s/ Amy C. Seidel, as Attorney-in-Fact for Jeffrey N. Simmons
Issuer symbol: ELAN
Transactions as of: 06 Feb 2026
Net transactions value: +$2,769
Form type: 4
Filing time: 10 Feb 2026, 16:32:53 UTC
Previous filing: 27 Jan 2026
Next filing: 24 Feb 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Simmons Jeffrey N	PRESIDENT, CEO AND DIRECTOR, Director	C/O ELANCO ANIMAL HEALTH INCORPORATED, 450 ELANCO CIRCLE, INDIANAPOLIS	/s/ Amy C. Seidel, as Attorney-in-Fact for Jeffrey N. Simmons	10 Feb 2026	0001479079

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ELAN	Deferred Stock Units	Award	$2,769	+110	+0.58%	$25.20	19,069	06 Feb 2026	Common Stock	110		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent.
F2	Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.